Article Details

Angel Pharma announces approval of IND application for clinical trial of mupadolimab

Retrieved on: 2022-09-27 17:36:52

Tags for this article:

Click the tags to see associated articles and topics

Angel Pharma announces approval of IND application for clinical trial of mupadolimab. View article details on HISWAI: https://www.labiotech.eu/trends-news/angel-pharma-announces-approval-of-ind-application-for-clinical-trial-of-mupadolimab/

Excerpt

Mupadolimab is a humanized monoclonal antibody directed against CD73. ... Compared to other anti-CD73 antibodies and small molecule drugs in ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up